Check Cap Stock

Check Cap EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Check Cap (MBAI) as of Aug 10, 2026 is -5.56. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -0.51 — a change of 990.53% (lower).

EV/EBITDA

-5.56

YoY

990.53%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Check Cap is 2026 -5.56 . EV/EBITDA (Enterprise Value to EBITDA) of Check Cap was 2025 -0.51 . It decreases by 990.53% lower compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

EV/EBITDA (Enterprise Value to EBITDA) of Check Cap is -5.56 in 2026.

EV/EBITDA (Enterprise Value to EBITDA) of Check Cap changed from -0.51 to -5.56, representing a 990.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Check Cap since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Check Cap with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Check Cap

All Key Metrics — Check Cap